Danaher Co. (NYSE:DHR) Shares Acquired by Vancity Investment Management Ltd

Vancity Investment Management Ltd grew its holdings in Danaher Co. (NYSE:DHRFree Report) by 15.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 99,063 shares of the conglomerate’s stock after buying an additional 13,406 shares during the period. Danaher makes up 3.4% of Vancity Investment Management Ltd’s holdings, making the stock its 7th biggest holding. Vancity Investment Management Ltd’s holdings in Danaher were worth $22,917,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. Nicholas Hoffman & Company LLC. raised its stake in shares of Danaher by 2.3% in the fourth quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock worth $439,000 after purchasing an additional 43 shares during the last quarter. Berger Financial Group Inc raised its stake in shares of Danaher by 1.7% in the fourth quarter. Berger Financial Group Inc now owns 2,517 shares of the conglomerate’s stock worth $582,000 after purchasing an additional 43 shares during the last quarter. Los Angeles Capital Management LLC raised its stake in shares of Danaher by 1.3% in the fourth quarter. Los Angeles Capital Management LLC now owns 3,470 shares of the conglomerate’s stock worth $803,000 after purchasing an additional 43 shares during the last quarter. Pinnacle Wealth Planning Services Inc. raised its stake in shares of Danaher by 1.0% in the fourth quarter. Pinnacle Wealth Planning Services Inc. now owns 4,329 shares of the conglomerate’s stock worth $1,001,000 after purchasing an additional 43 shares during the last quarter. Finally, Drive Wealth Management LLC raised its stake in shares of Danaher by 3.1% in the fourth quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock worth $344,000 after purchasing an additional 44 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Down 0.1 %

NYSE DHR traded down $0.16 on Friday, reaching $254.85. 3,018,991 shares of the company were exchanged, compared to its average volume of 2,771,155. The business’s fifty day moving average price is $253.48 and its 200 day moving average price is $244.13. The stock has a market capitalization of $188.76 billion, a P/E ratio of 43.19, a price-to-earnings-growth ratio of 4.05 and a beta of 0.85. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $269.11.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. During the same quarter in the previous year, the business earned $2.36 earnings per share. The company’s revenue for the quarter was down 2.6% on a year-over-year basis. Analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 0.42%. Danaher’s dividend payout ratio is presently 18.31%.

Insider Activity at Danaher

In related news, CEO Rainer Blair sold 47,175 shares of the business’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total value of $11,756,953.50. Following the sale, the chief executive officer now owns 115,995 shares in the company, valued at approximately $28,908,273.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Danaher news, CEO Rainer Blair sold 47,175 shares of the company’s stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the sale, the chief executive officer now owns 115,995 shares in the company, valued at approximately $28,908,273.90. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Alan G. Spoon sold 708 shares of the company’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total value of $172,454.64. Following the sale, the director now owns 116,202 shares in the company, valued at approximately $28,304,483.16. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 148,783 shares of company stock worth $37,536,717. 11.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

DHR has been the subject of several research analyst reports. Bank of America raised their price objective on Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 24th. Robert W. Baird lifted their price target on Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research report on Wednesday, April 24th. TD Cowen lifted their price target on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Citigroup lifted their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Finally, Barclays lifted their price target on Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 24th. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $269.29.

Check Out Our Latest Report on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.